GSK-MEK111054

Study Sponsor: GSK

Study Title

An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor GSK1120212 in Subjects with Solid Tumors or Lymphoma

Medicine or Vaccine (generic name)

trametinib

Sponsor Identification Number

MEK111054

Trial Registry Identification Number(#'s)

NCT00687622

Medical Condition

Solid Tumours

Phase

Phase 1

Link to GSK Study Register

http://www.gsk-clinicalstudyregister.com/study/MEK111054

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00687622

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2013